Simbec-Orion Expands Immunoassay Capability

In line with our continuing investment in technology, we have recently expanded our immunoassay capability with the addition of a second Ella™ ELISA analyser from ProteinSimple.

Utilising Simple PlexTM technology, EllaTM is providing Simbec-Orion clients with access to an extensive library of key immunoassays to support the measurement of both the immunogenic potential and pharmacodynamic responses of key biomarkers of a therapeutic candidate, in a range of matrices. Using this technology enables measurement with greater sensitivity whilst utilising a reduced sample volume, wider dynamic detection ranges and, thanks to the lack of antibody cross-reactivity in multianalyte assays, increased accuracy of simultaneously performed assays.

Whether you require support with relevant markers to advance your drug development research, or data for clinical trials to determine dosing schedules and safety information, Simbec-Orion offers a combination of customisable assay library, with a high throughput, fully integrated and automated process. This ensures cost-effective, versatile, biomarker analysis for your clinical development programme.

Connect with a scientist to learn more

Back to News Archive